Advertisement

Impact of Insulin-Treated and Noninsulin-Treated Diabetes Mellitus in All-Comer Patients Undergoing Percutaneous Coronary Interventions With Polymer-Free Biolimus-Eluting Stent (from the RUDI-FREE Registry)

      Patients with diabetes mellitus (DM) have worse outcomes after percutaneous coronary intervention (PCI). Recent evidences suggest a differential impact of insulin-treated and noninsulin-treated DM on prognosis. We evaluated the clinical outcome of diabetic patients after PCI with polymer-free biolimus-eluting stent from the RUDI-FREE Registry, investigating a possible different prognostic impact of insulin-treated and noninsulin-treated DM. A total of 1,104 consecutive patients who underwent PCI with polymer-free biolimus-eluting stent, enrolled in the RUDI-FREE observational, multicenter, single-arm registry, were stratified by diabetic status; diabetic population was further divided on the basis of insulin treatment. Primary end points of the study were target lesion failure (TLF; composite of cardiac death, target vessel myocardial infarction, target lesion revascularization) and major adverse cardiac and cerebrovascular events (composite of cardiac death, stroke, and myocardial infarction). Multiple ischemic adverse events were also single-handedly considered as secondary end points. At 1 year, TLF was significantly higher in the diabetic cohort, as compared with nondiabetic patients (6.0% vs 3.1%, p 0.022). None of the end points resulted significantly different between nondiabetics and noninsulin-treated diabetic patients. Divergently, compared with nondiabetic, insulin-treated diabetic patients faced significant higher rates of TLF (10.8% vs 3.1%, p 0.003), major adverse cardiac and cerebrovascular events (10.8% vs 3.4%, p 0.004), and of most of the analyzed adverse events. In conclusion, patients with DM had a higher risk of TLF compared with nondiabetics; nonetheless, the worse outcome of the diabetic population seems to be driven by the insulin-treated diabetic subpopulation. This finding suggests a different risk profile of insulin-treated and noninsulin-treated diabetic patients in the modern era of PCI.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Grundy SM
        • D'Agostino RB
        • Mosca L
        • Burke GL
        • Wilson PW
        • Rader DJ
        • Cleeman JI
        • Roccella EJ
        • Cutler JA
        • Friedman LM
        Cardiovascular risk assessment based on US cohort studies: findings from a National Heart, Lung, and Blood institute workshop.
        Circulation. 2001; 104: 491-496
        • Rydén L
        • Grant PJ
        • Anker SD
        • Berne C
        • Cosentino F
        • Danchin N
        • Deaton C
        • Escaned J
        • Hammes HP
        • Huikuri H
        • Marre M
        • Marx N
        • Mellbin L
        • Ostergren J
        • Patrono C
        • Seferovic P
        • Uva MS
        • Taskinen MR
        • Tendera M
        • Tuomilehto J
        • Valensi P
        • Zamorano JL
        • Achenbach S
        • Baumgartner H
        • Bax JJ
        • Bueno H
        • Dean V
        • Erol C
        • Fagard R
        • Ferrari R
        • Hasdai D
        • Hoes AW
        • Kirchhof P
        • Knuuti J
        • Kolh P
        • Lancellotti P
        • Linhart A
        • Nihoyannopoulos P
        • Piepoli MF
        • Ponikowski P
        • Sirnes PA
        • Tamargo JL Torbicki A
        • Wijns W
        • Windecker S
        • De Backer G
        • Ezquerra EA
        • Avogaro A
        • Badimon L
        • Baranova E
        • Betteridge J
        • Ceriello A
        • Funck-Brentano C
        • Gulba DC
        • Kjekshus JK
        • Lev E
        • Mueller C
        • Neyses L
        • Nilsson PM
        • Perk J
        • Reiner Z
        • Sattar N
        • Schächinger V
        • Scheen A
        • Schirmer H
        • Strömberg A
        • Sudzhaeva S
        • Viigimaa M
        • Vlachopoulos C
        • Xuereb RG
        • Authors/Task Force Members, ESC Committee for Practice Guidelines (CPG), and Document Reviewers
        ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD).
        Eur Heart J. 2013; 34: 3035-3087
        • Konigstein M
        • Ben-Yehuda O
        • Smits PC
        • Love MP
        • Banai S
        • Perlman GY
        • Golomb M
        • Ozan MO
        • Liu M
        • Leon MB
        • Stone GW
        • Kandzari DE
        Outcomes among diabetic patients undergoing percutaneous coronary intervention with contemporary drug-eluting stents: analysis from the BIONICS randomized trial.
        JACC Cardiovasc Interv. 2018; 11: 2467-2476
        • Mathew V
        • Gersh BJ
        • Williams BA
        • Laskey WK
        • Willerson JT
        • Tilbury RT
        • Davis BR
        • Holmes DR
        Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial.
        Circulation. 2004; 109: 476-480
        • Sabaté M
        • Jiménez-Quevedo P
        • Angiolillo DJ
        • Gómez-Hospital JA
        • Alfonso F
        • Hernández-Antolín R
        • Goicolea J
        • Bañuelos C
        • Escaned J
        • Moreno R
        • Fernández C
        • Fernández-Avilés F
        • Macaya C
        • DIABETES Investigators
        Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.
        Circulation. 2005; 112: 2175-2183
        • Mulukutla SR
        • Vlachos HA
        • Marroquin OC
        • Selzer F
        • Holper EM
        • Abbott JD
        • Laskey WK
        • Williams DO
        • Smith C
        • Anderson WD
        • Lee JS
        • Srinivas V
        • Kelsey SF
        • Kip KE
        Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic Registry.
        JACC Cardiovasc Interv. 2008; 1: 139-147
        • Kedhi E
        • Gomes ME
        • Lagerqvist B
        • Smith J G
        • Omerovic E
        • James S Harnek J
        • Olivecrona GK
        Clinical impact of second-generation everolimus-eluting stent compared with first-generation drug-eluting stents in diabetes mellitus patients: insights from a nationwide coronary intervention register.
        JACC Cardiovasc Interv. 2012; 5: 1141-1149
        • Iakovou I
        • Schmidt T
        • Bonizzoni E
        • Ge L
        • Sangiorgi GM
        • Stankovic G
        • Airoldi F
        • Chieffo A
        • Montorfano M
        • Carlino M
        • Michev I
        • Corvaja N
        • Briguori C
        • Gerckens U
        • Grube E
        • Colombo A
        Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.
        JAMA. 2005; 293: 2126-2130
        • Hong SJ
        • Kim MH
        • Ahn TH
        • Ahn YK
        • Bae JH
        • Shim WJ
        • Ro YM
        • Lim DS
        Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes.
        Heart. 2006; 92: 1119-1124
        • Akin I
        • Bufe A
        • Eckardt L
        • Reinecke H
        • Senges J
        • Richardt G
        • Kuck KH
        • Schneider S
        • Nienaber CA
        • Group DDS
        Comparison of outcomes in patients with insulin-dependent versus non-insulin dependent diabetes mellitus receiving drug-eluting stents (from the first phase of the prospective multicenter German DES.DE registry).
        Am J Cardiol. 2010; 106: 1201-1207
        • Silber S
        • Serruys PW
        • Leon MB
        • Meredith IT
        • Windecker S
        • Neumann FJ
        • Belardi J
        • Widimsky P
        • Massaro J
        • Novack V
        • Yeung AC
        • Saito S
        • Mauri L
        Clinical outcome of patients with and without diabetes mellitus after percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the prospectively pooled analysis of the international global RESOLUTE program.
        JACC Cardiovasc Interv. 2013; 6: 357-368
        • Park KW
        • Lee JM
        • Kang SH
        • Ahn HS
        • Kang HJ
        • Koo BK
        • Rhew JY
        • Hwang SH
        • Lee SY
        • Kang TS
        • Kwak CH
        • Hong BK
        • Yu CW
        • Seong IW
        • Ahn T
        • Lee HC
        • Lim SW
        • Kim HS
        Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.
        JACC Cardiovasc Interv. 2014; 7: 471-481
        • Bangalore S
        • Bhagwat A
        • Pinto B
        • Goel PK
        • Jagtap P
        • Sathe S
        • Arambam P
        • Kaul U
        Percutaneous coronary intervention in patients with insulin-treated and non-insulin-treated diabetes mellitus: secondary analysis of the TUXEDO trial.
        JAMA Cardiol. 2016; 1: 266-273
        • Garot P
        • Morice MC
        • Tresukosol D
        • Pocock SJ
        • Meredith IT
        • Abizaid A
        • Carrié D
        • Naber C
        • Iñiguez A
        • Talwar S
        • Menown IBA
        • Christiansen EH
        • Gregson J
        • Copt S
        • Hovasse T
        • Lurz P
        • Maillard L
        • Krackhardt F
        • Ong P
        • Byrne J
        • Redwood S
        • Windhövel U
        • Greene S
        • Stoll HP
        • Urban P
        • Investigators LF
        2-year outcomes of high bleeding risk patients after polymer-free drug-coated stents.
        J Am Coll Cardiol. 2017; 69: 162-171
        • Sardella G
        • Stefanini GG
        • Briguori C
        • Tamburino C
        • Fabbiocchi F
        • Rotolo F
        • Tomai F
        • Paggi A
        • Lombardi M
        • Gioffrè G
        • Sclafani R
        • Rolandi A
        • Sciahbasi A
        • Scardaci F
        • Signore N
        • Calcagno S
        • Mancone M
        • Chiarito M
        • Giordano A
        Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients: the RUDI-FREE study.
        EuroIntervention. 2018; 14: 772-779
        • Association AD
        Diagnosis and classification of diabetes mellitus.
        Diabetes Care. 2010; 33: S62-S69
        • Giustino G
        • Chieffo A
        • Palmerini T
        • Valgimigli M
        • Feres F
        • Abizaid A
        • Costa RA
        • Hong MK
        • Kim BK
        • Jang Y
        • Kim HS
        • Park KW
        • Gilard M
        • Morice MC
        • Sawaya F
        • Sardella G
        • Genereux P
        • Redfors B
        • Leon MB
        • Bhatt DL
        • Stone GW
        • Colombo A
        Efficacy and safety of dual antiplatelet therapy after complex PCI.
        J Am Coll Cardiol. 2016; 68: 1851-1864
        • Thygesen K
        • Alpert JS
        • Jaffe AS
        • Chaitman BR
        • Bax JJ
        • Morrow DA
        • White HD
        • ESC Scientific Document Group
        Fourth universal definition of myocardial infarction (2018).
        Eur Heart J. 2019; 40: 237-269
        • Mauri L
        • Hsieh WH
        • Massaro JM
        • Ho KK
        • D'Agostino R
        • Cutlip DE
        Stent thrombosis in randomized clinical trials of drug-eluting stents.
        N Engl J Med. 2007; 356: 1020-1029
        • Pepe M
        • Cafaro A
        • Paradies V
        • Signore N
        • Addabbo F
        • Bortone AS
        • Navarese EP
        • Contegiacomo G
        • Forleo C
        • Bartolomucci F
        • Di Cillo O
        • Bianchi FP
        • Zanna D
        • Favale S
        Time-dependent benefits of pre-treatment with new oral P2Y.
        Catheter Cardiovasc Interv. 2019; 93: 592-601
        • Pepe M
        • Zanna D
        • Cafaro A
        • Marchese A
        • Addabbo F
        • Navarese EP
        • Napodano M
        • Cecere A
        • Resta F
        • Paradies V
        • Bortone AS
        • Favale S
        Role of plasma glucose level on myocardial perfusion in ST-segment elevation myocardial infarction patients.
        J Diabetes Complicat. 2018; 32: 764-769
        • Tada T
        • Kimura T
        • Morimoto T
        • Ono K
        • Furukawa Y
        • Nakagawa Y
        • Nakashima H
        • Ito A
        • Siode N
        • Namura M
        • Inoue N
        • Nishikawa H
        • Nakao K
        • Mitsudo K
        • j-Cypher Registry Investigators
        Comparison of three-year clinical outcomes after sirolimus-eluting stent implantation among insulin-treated diabetic, non-insulin-treated diabetic, and non-diabetic patients from j-Cypher registry.
        Am J Cardiol. 2011; 107: 1155-1162
        • Dangas GD
        • Farkouh ME
        • Sleeper LA
        • Yang M
        • Schoos MM
        • Macaya C
        • Abizaid A
        • Buller CE
        • Devlin G
        • Rodriguez AE
        • Lansky AJ
        • Siami FS
        • Domanski M
        • Fuster V
        • FREEDOM Investigators
        Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial.
        J Am Coll Cardiol. 2014; 64: 1189-1197
        • Pi SH
        • Rhee TM
        • Lee JM
        • Hwang D
        • Park J
        • Park TK
        • Yang JH
        • Song YB
        • Choi JH
        • Hahn JY
        • Kim BJ
        • Kim BS
        • Gwon HC
        • Choi SH
        Outcomes in patients with diabetes mellitus according to insulin treatment after percutaneous coronary intervention in the second-generation drug-eluting stent era.
        Am J Cardiol. 2018; 121: 1505-1511
        • Potenza MA
        • Addabbo F
        • Montagnani M
        Vascular actions of insulin with implications for endothelial dysfunction.
        Am J Physiol Endocrinol Metab. 2009; 297: E568-E577
        • Wang CC
        • Goalstone ML
        • Draznin B
        Molecular mechanisms of insulin resistance that impact cardiovascular biology.
        Diabetes. 2004; 53: 2735-2740
        • Iguchi T
        • Hasegawa T
        • Otsuka K
        • Matsumoto K
        • Yamazaki T
        • Nishimura S
        • Nakata S
        • Ehara S
        • Kataoka T
        • Shimada K
        • Yoshiyama M
        Insulin resistance is associated with coronary plaque vulnerability: insight from optical coherence tomography analysis.
        Eur Heart J Cardiovasc Imaging. 2014; 15 (284-29)
        • D'Ascenzo F
        • Bertaina M
        • Fioravanti F
        • Bongiovanni F
        • Raposeiras-Roubin S
        • Abu-Assi E
        • Kinnaird T
        • Ariza-Solé A
        • Manzano-Fernández S
        • Templin C
        • Velicki L
        • Xanthopoulou I
        • Cerrato E
        • Rognoni A
        • Boccuzzi G
        • Omedè P
        • Montabone A
        • Taha S
        • Durante A
        • Gili S
        • Magnani G
        • Autelli M
        • Grosso A
        • Blanco PF
        • Garay A
        • Quadri G
        • Varbella F
        • Queija BC
        • Paz RC
        • Fernández MC
        • Pousa IM
        • Gallo D
        • Morbiducci U
        • Dominguez-Rodriguez A
        • Valdés M
        • Cequier A
        • Alexopoulos D
        • Iñiguez-Romo A
        • Gaita F
        • Rinaldi M
        • Lüscher TF
        Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry.
        Eur J Prev Cardiol. 2019; ([Epub ahead of print])https://doi.org/10.1177/2047487319836327
        • Pepe M
        • Biondi-Zoccai G
        • Corcione N
        • Nestola PL
        • Ferraro P
        • Morello A
        • Conte S
        • Prati F
        • Bianchi FP
        • Bortone AS
        • Giordano A
        Comparative effectiveness and safety of polymer-free biolimus-eluting stent and durable polymer everolimus-eluting stent in all-comer patients who underwent percutaneous coronary interventions.
        Am J Cardiol. 2019; 124: 195-204
        • Chiarito M
        • Sardella G
        • Colombo A
        • Briguori C
        • Testa L
        • Bedogni F
        • Fabbiocchi F
        • Paggi A
        • Palloshi A
        • Tamburino C
        • Margonato A
        • Pivato CA
        • Baber U
        • Calcagno S
        • Giordano A
        • Godino C
        • Stefanini GG
        Safety and efficacy of polymer-free drug-eluting stents.
        Circ Cardiovasc Interv. 2019; 12e007311
        • Neumann FJ
        • Sousa-Uva M
        • Ahlsson A
        • Alfonso F
        • Banning AP
        • Benedetto U
        • Byrne RA
        • Collet JP
        • Falk V
        • Head SJ
        • Jüni P
        • Kastrati A
        • Koller A
        • Kristensen SD
        • Niebauer J
        • Richter DJ
        • Seferovic PM
        • Sibbing D
        • Stefanini GG
        • Windecker S
        • Yadav R
        • Zembala MO
        • Group ESD
        2018 ESC/EACTS guidelines on myocardial revascularization.
        Eur Heart J. 2019; 40: 87-165
        • Fihn SD
        • Blankenship JC
        • Alexander KP
        • Bittl JA
        • Byrne JG
        • Fletcher BJ
        • Fonarow GC
        • Lange RA
        • Levine GN
        • Maddox TM
        • Naidu SS
        • Ohman EM
        • Smith PK
        2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
        J Am Coll Cardiol. 2014; 64: 1929-1949